D455-0361 Screening compound: 6-(4-fluorophenyl)-N~5~-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-imidazo[2,1-b][1,3]thiazole-5-carboxamide

D455-0361 Screening compound: 6-(4-fluorophenyl)-N~5~-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-imidazo[2,1-b][1,3]thiazole-5-carboxamide
D455-0361 Screening compound: 6-(4-fluorophenyl)-N~5~-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-imidazo[2,1-b][1,3]thiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D455-0361
6-(4-fluorophenyl)-N~5~-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-imidazo[2,1-b][1,3]thiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D455-0361

Molecular Formula

C22H17FN4O3S2 (C22 H17 FN4 O3 S2)

Compound Name

6-(4-fluorophenyl)-N~5~-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-1,1-dioxo-2,3-dihydro-1H-1lambda~6~-imidazo[2,1-b][1,3]thiazole-5-carboxamide

IUPAC name

6-(4-fluorophenyl)-N-[4-(4-methylphenyl)-13-thiazol-2-yl]-11-dioxo-2H3H-1lambda6-imidazo[21-b][13]thiazole-5-carboxamide

SMILES

Cc(cc1)ccc1-c1csc(NC(c(n2CC3)c(-c(cc4)ccc4F)nc2S3(=O)=O)=O)n1

InChI

InChI=1S/C22H17FN4O3S2/c1-13-2-4-14(5-3-13)17-12-31-21(24-17)26-20(28)19-18(15-6-8-16(23)9-7-15)25-22-27(19)10-11-32(22,29)30/h2-9,12H,10-11H2,1H3,(H,24,26,28)

InChI Key

FTWWZXAAYLZDJV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27587286

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.53

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.757

Distribution Coefficient, logD

4.756

Water Solubility, LogSw

-4.41

Polar Surface Area

74.382

Acid Dissociation Constant (pKa)

10.19

Base Dissociation Constant (pKb)

0.22

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.60

D455-0361 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with D455-0361 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D455-0361?
Check Price and Availability of D455-0361, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D455-0361 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D455-0361
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D455-0361
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D455-0361 available by request